https://www.astrazeneca.it/ 2026-07-28T08:25:00.674Z https://www.astrazeneca.it/pazientieassociazioni.html 2026-02-09T14:26:19.914Z https://www.astrazeneca.it/search-results.html 2017-01-19T17:07:35.668Z https://www.astrazeneca.it/500.html 2016-06-20T09:45:16.838Z https://www.astrazeneca.it/503.html 2016-06-20T09:44:54.203Z https://www.astrazeneca.it/404.html 2016-12-05T17:57:59.478Z https://www.astrazeneca.it/lavoraconnoi.html 2024-10-16T14:37:05.980Z https://www.astrazeneca.it/lavoraconnoi/carriere.html 2024-10-15T13:55:51.431Z https://www.astrazeneca.it/lavoraconnoi/early-talent.html 2024-10-14T15:52:06.090Z https://www.astrazeneca.it/chi-siamo.html 2024-12-02T14:39:32.958Z https://www.astrazeneca.it/chi-siamo/generiamo-valore.html 2026-06-03T08:03:53.408Z https://www.astrazeneca.it/chi-siamo/generiamo-valore/capitale-economico.html 2024-11-22T15:11:48.895Z https://www.astrazeneca.it/chi-siamo/generiamo-valore/capitale-cognitivo.html 2024-11-25T09:37:04.054Z https://www.astrazeneca.it/chi-siamo/generiamo-valore/capitale-sociale.html 2024-11-25T09:37:57.063Z https://www.astrazeneca.it/chi-siamo/generiamo-valore/capitale-ambientale.html 2024-11-27T14:50:31.576Z https://www.astrazeneca.it/chi-siamo/la-nostra-azienda.html 2026-06-03T08:05:55.091Z https://www.astrazeneca.it/chi-siamo/astrazeneca-in-mind.html 2026-05-29T07:48:36.904Z https://www.astrazeneca.it/chi-siamo/codice-etico.html 2026-06-03T08:06:52.659Z https://www.astrazeneca.it/aree-terapeutiche.html 2016-12-16T14:43:34.799Z https://www.astrazeneca.it/aree-terapeutiche/oncologia.html 2026-05-11T12:15:07.789Z https://www.astrazeneca.it/aree-terapeutiche/oncologia/endofsilence.html 2026-05-13T11:51:21.951Z https://www.astrazeneca.it/aree-terapeutiche/malattie-cardiovascolari-renali-metaboliche.html 2018-03-14T09:26:55.434Z https://www.astrazeneca.it/aree-terapeutiche/malattie-respiratorie-infiammatorie-autoimmuni1.html 2018-03-12T11:55:24.270Z https://www.astrazeneca.it/sostenibilita.html 2026-07-28T10:24:25.217Z https://www.astrazeneca.it/sostenibilita/politica-della-qualita.html 2026-07-24T08:39:51.755Z https://www.astrazeneca.it/sostenibilita/politica-ambientale.html 2026-07-24T08:40:13.263Z https://www.astrazeneca.it/sostenibilita/politica-parita-di-genere.html 2026-07-24T08:50:23.666Z https://www.astrazeneca.it/sostenibilita/young-health-programme.html 2026-07-24T08:40:32.178Z https://www.astrazeneca.it/area-stampa.html 2024-03-12T06:08:12.758Z https://www.astrazeneca.it/area-stampa/press-releases.html 2017-11-29T13:13:51Z https://www.astrazeneca.it/area-stampa/press-releases/2016.html 2016-12-19T17:43:07.024Z https://www.astrazeneca.it/area-stampa/press-releases/2016/astraZeneca-stipula-due-accordi-di-licenza-con-leo-pharmap-er-il-trattamento-delle-malattie-cutanee.html 2016-12-01T11:06:35.679Z https://www.astrazeneca.it/area-stampa/press-releases/2016/ceftazidime-avibactam-approvato-nell-unione-europea-per-il-trattamento-dei-pazienti-con-gravi-infezioni-batteriche.html 2016-07-21T13:38:01.088Z https://www.astrazeneca.it/area-stampa/press-releases/2016/osimertinib_AURA3.html 2017-11-29T13:06:26.941Z https://www.astrazeneca.it/area-stampa/press-releases/2016/ceftazidime-avibactam.html 2016-12-01T11:17:24.788Z https://www.astrazeneca.it/area-stampa/press-releases/2016/selumetinib.html 2016-12-01T11:24:11.642Z https://www.astrazeneca.it/area-stampa/press-releases/2016/Pfizer.html 2016-12-01T11:29:37.320Z https://www.astrazeneca.it/area-stampa/press-releases/2016/osimertinib_CE.html 2016-12-01T11:39:31.273Z https://www.astrazeneca.it/area-stampa/press-releases/2016/Top_Employer.html 2016-12-01T11:45:55.692Z https://www.astrazeneca.it/area-stampa/press-releases/2016/Voluntis.html 2016-12-01T11:47:00.916Z https://www.astrazeneca.it/area-stampa/press-releases/2016/secretomics.html 2016-12-01T11:47:55.251Z https://www.astrazeneca.it/area-stampa/press-releases/2016/incyte.html 2016-12-01T13:13:07.279Z https://www.astrazeneca.it/area-stampa/press-releases/2016/ricerca_traslazionale.html 2016-12-01T13:20:39.562Z https://www.astrazeneca.it/area-stampa/press-releases/2016/moderna_therapeutics.html 2016-12-01T13:23:55.220Z https://www.astrazeneca.it/area-stampa/press-releases/2016/acerta_pharma.html 2016-12-01T13:32:44.097Z https://www.astrazeneca.it/area-stampa/press-releases/2016/consorzio-RCP2.html 2016-12-01T13:35:19.660Z https://www.astrazeneca.it/area-stampa/press-releases/2016/lynparza-breakthroughTherapy.html 2016-12-01T13:47:19.035Z https://www.astrazeneca.it/area-stampa/press-releases/2016/durvalumab-breakthroughTherapy.html 2016-12-01T13:53:03.579Z https://www.astrazeneca.it/area-stampa/press-releases/2016/acalabrutinib_EMA.html 2016-12-01T14:09:09.550Z https://www.astrazeneca.it/area-stampa/press-releases/2016/lesinurad.html 2016-12-01T14:18:33.872Z https://www.astrazeneca.it/area-stampa/press-releases/2016/felodipina.html 2016-12-01T14:21:05.412Z https://www.astrazeneca.it/area-stampa/press-releases/2016/MEDI8852_FDA_Fast_Track.html 2016-12-01T14:24:20.831Z https://www.astrazeneca.it/area-stampa/press-releases/2016/MEDI551_Orphan_Drug.html 2016-12-01T14:27:20.428Z https://www.astrazeneca.it/area-stampa/press-releases/2016/moventig_Prostrakan.html 2016-12-01T14:39:14.805Z https://www.astrazeneca.it/area-stampa/press-releases/2016/risultati_Socrates.html 2016-12-01T14:49:57.442Z https://www.astrazeneca.it/area-stampa/press-releases/2016/PLAIV_CHMP.html 2016-12-01T14:53:19.980Z https://www.astrazeneca.it/area-stampa/press-releases/2016/Linee-guida-ACC-AHA-ticagrelor.html 2017-11-29T13:06:49.571Z https://www.astrazeneca.it/area-stampa/press-releases/2016/elcc_osimertinib.html 2016-12-01T15:00:32.433Z https://www.astrazeneca.it/area-stampa/press-releases/2016/olaparib.html 2017-11-29T13:05:52.245Z https://www.astrazeneca.it/area-stampa/press-releases/2016/ECCMID-2016.html 2020-03-11T09:37:47.855Z https://www.astrazeneca.it/area-stampa/press-releases/2016/FDA-glicopirrolato.html 2016-12-01T15:10:30.095Z https://www.astrazeneca.it/area-stampa/press-releases/2016/ricercagenomica.html 2016-12-01T16:02:48.992Z https://www.astrazeneca.it/area-stampa/press-releases/2016/ironwwod.html 2016-12-01T16:07:29.967Z https://www.astrazeneca.it/area-stampa/press-releases/2016/CAZ-AVI-CHMP.html 2016-12-01T16:11:12.596Z https://www.astrazeneca.it/area-stampa/press-releases/2016/selumetinib_farmacoorfano.html 2017-11-29T13:07:11.461Z https://www.astrazeneca.it/area-stampa/press-releases/2016/benralizumab_sirocco_calima.html 2017-11-29T13:07:35.447Z https://www.astrazeneca.it/area-stampa/press-releases/2016/olaparib_GOLD.html 2017-11-29T13:09:24.898Z https://www.astrazeneca.it/area-stampa/press-releases/2016/takeda.html 2016-12-01T16:25:25.571Z https://www.astrazeneca.it/area-stampa/press-releases/2016/Fulvestrant_FALCON.html 2020-03-11T09:32:04.954Z https://www.astrazeneca.it/area-stampa/press-releases/2016/Saxa-dapa-CHMP.html 2016-12-01T16:45:56.817Z https://www.astrazeneca.it/area-stampa/press-releases/2016/osimertinibasco2016.html 2016-12-01T16:46:43.738Z https://www.astrazeneca.it/area-stampa/press-releases/2016/olaparibasco2016.html 2016-12-01T16:51:09.854Z https://www.astrazeneca.it/area-stampa/press-releases/2016/durvalumabasco2016.html 2016-12-01T16:54:23.733Z https://www.astrazeneca.it/area-stampa/press-releases/2016/lesinurad1.html 2016-12-01T17:01:39.223Z https://www.astrazeneca.it/area-stampa/press-releases/2016/accordoaspen.html 2016-12-01T17:05:07.338Z https://www.astrazeneca.it/area-stampa/press-releases/2016/accordoolaparivconFMI.html 2016-12-01T17:25:09.908Z https://www.astrazeneca.it/area-stampa/press-releases/2016/benralizumabERS.html 2016-12-01T17:40:32.384Z https://www.astrazeneca.it/area-stampa/press-releases/2016/dapagliflozin.html 2016-12-01T17:45:15.983Z https://www.astrazeneca.it/area-stampa/press-releases/2016/exenatide.html 2016-12-01T17:50:09.750Z https://www.astrazeneca.it/area-stampa/press-releases/2016/cediranib.html 2016-12-01T17:53:30.330Z https://www.astrazeneca.it/area-stampa/press-releases/2016/davidgoldstein.html 2016-12-01T17:56:49.914Z https://www.astrazeneca.it/area-stampa/press-releases/2016/fulvestrantESMO.html 2016-12-01T17:59:29.967Z https://www.astrazeneca.it/area-stampa/press-releases/2016/allergan.html 2016-12-01T18:06:49.265Z https://www.astrazeneca.it/area-stampa/press-releases/2016/aralez.html 2016-12-01T18:12:22.933Z https://www.astrazeneca.it/area-stampa/press-releases/2016/fulvestrant_esmo.html 2021-02-19T16:34:06.690Z https://www.astrazeneca.it/area-stampa/press-releases/2016/euclid.html 2016-12-01T18:17:57.205Z https://www.astrazeneca.it/area-stampa/press-releases/2016/durvalumabesmo.html 2016-12-01T18:36:32.520Z https://www.astrazeneca.it/area-stampa/press-releases/2016/olaparibsolo2.html 2016-12-01T18:22:49.090Z https://www.astrazeneca.it/area-stampa/press-releases/2016/testBRCA.html 2016-12-01T18:25:13.155Z https://www.astrazeneca.it/area-stampa/press-releases/2016/congressiscientifici.html 2016-12-02T10:50:05.262Z https://www.astrazeneca.it/area-stampa/press-releases/2016/accordo_Cilag.html 2016-12-19T17:40:05.462Z https://www.astrazeneca.it/area-stampa/press-releases/2016/durvalumab.html 2016-12-19T17:16:52.713Z https://www.astrazeneca.it/area-stampa/press-releases/2017.html 2017-11-29T10:29:50.837Z https://www.astrazeneca.it/area-stampa/press-releases/2017/ZS9_iperkaliemia_ZSPharma.html 2017-03-02T13:30:19.384Z https://www.astrazeneca.it/area-stampa/press-releases/2017/osimertinib_FDAUSA.html 2017-04-03T15:38:08.663Z https://www.astrazeneca.it/area-stampa/press-releases/2017/Osimertinib_BTD.html 2017-10-25T09:49:45.223Z https://www.astrazeneca.it/area-stampa/press-releases/2017/FLAURA_tumore_al_polmone1.html 2017-09-15T15:55:22.062Z https://www.astrazeneca.it/area-stampa/press-releases/2017/osimertinib_cFDA.html 2017-03-31T12:35:58.714Z https://www.astrazeneca.it/area-stampa/press-releases/2017/Olaparib_carcinomamammario_OlympiAD.html 2020-03-11T09:42:45.369Z https://www.astrazeneca.it/area-stampa/press-releases/2017/MedImmune_SanofiPasteur_MEDI8897.html 2017-03-13T17:26:22.998Z https://www.astrazeneca.it/area-stampa/press-releases/2017/Olaparib_OlympiAD.html 2017-03-02T15:04:40.114Z https://www.astrazeneca.it/area-stampa/press-releases/2017/Durvalumab_EMA.html 2017-10-25T09:58:27.570Z https://www.astrazeneca.it/area-stampa/press-releases/2017/exenatide_studioEXSCEL.html 2017-06-01T12:57:34.288Z https://www.astrazeneca.it/area-stampa/press-releases/2017/CVD_Real_SGLT2.html 2017-03-21T11:37:53.449Z https://www.astrazeneca.it/area-stampa/press-releases/2017/Olaparib_tumoreovarico_studioSOLO2.html 2017-06-14T08:11:50.388Z https://www.astrazeneca.it/area-stampa/press-releases/2017/diabete_dapagliflozin_saxagliptin.html 2017-03-13T16:21:41.105Z https://www.astrazeneca.it/area-stampa/press-releases/2017/dapagliflozin_ADA.html 2017-06-15T08:35:48.458Z https://www.astrazeneca.it/area-stampa/press-releases/2017/benralizumab_ZONDA.html 2017-06-01T13:27:25.331Z https://www.astrazeneca.it/area-stampa/press-releases/2017/Neuromieliteottica.html 2017-03-31T12:14:58.273Z https://www.astrazeneca.it/area-stampa/press-releases/2017/Olaparib_BRCA_SOLO2.html 2017-03-21T11:35:27.456Z https://www.astrazeneca.it/area-stampa/press-releases/2017/durvalumab_breakthrough therapy designation.html 2017-08-30T12:41:19.628Z https://www.astrazeneca.it/area-stampa/press-releases/2017/linfoma_mantellare.html 2017-08-30T14:52:17.248Z https://www.astrazeneca.it/area-stampa/press-releases/2017/durvalumab_StudioPACIFIC.html 2017-05-16T08:19:01.081Z https://www.astrazeneca.it/area-stampa/press-releases/2017/durvalumab_approvazioneFDA.html 2017-05-05T15:15:07.969Z https://www.astrazeneca.it/area-stampa/press-releases/2017/PACIFIC_tumore_al_polmone.html 2017-09-15T15:27:32.095Z https://www.astrazeneca.it/area-stampa/press-releases/2017/osimertinib_rimborsabile.html 2017-08-30T14:33:21.241Z https://www.astrazeneca.it/area-stampa/press-releases/2017/brodalumab.html 2017-02-22T11:01:25.058Z https://www.astrazeneca.it/area-stampa/press-releases/2017/budesonide_formoterolo_spray.html 2017-10-04T14:20:01.645Z https://www.astrazeneca.it/area-stampa/press-releases/2017/goserelin.html 2017-02-23T13:11:31.093Z https://www.astrazeneca.it/area-stampa/press-releases/2017/ZS-9_iperkaliemia.html 2017-03-27T08:16:18.184Z https://www.astrazeneca.it/area-stampa/press-releases/2017/Cambridge_nuovasede.html 2017-05-05T15:18:13.866Z https://www.astrazeneca.it/area-stampa/press-releases/2017/osimertinib_tumorealpolmone_AURA3.html 2017-06-14T08:23:52.360Z https://www.astrazeneca.it/area-stampa/press-releases/2017/TopEmployers2017.html 2017-02-08T17:15:05.817Z https://www.astrazeneca.it/area-stampa/press-releases/2017/Circassia_patologierespiratorie.html 2017-03-31T08:24:23.926Z https://www.astrazeneca.it/area-stampa/press-releases/2017/AACR_oncologia.html 2017-03-31T12:05:43.643Z https://www.astrazeneca.it/area-stampa/press-releases/2017/immunoncologia.html 2017-01-26T10:41:39.755Z https://www.astrazeneca.it/area-stampa/press-releases/2017/Patient Advocacy Network.html 2017-06-12T09:15:40.823Z https://www.astrazeneca.it/area-stampa/press-releases/2017/benralizumab.html 2017-11-14T14:08:17.355Z https://www.astrazeneca.it/area-stampa/press-releases/2017/GlobalDiabetesPolicyForum.html 2017-10-25T10:02:23.903Z https://www.astrazeneca.it/area-stampa/press-releases/2017/acalabrutinib.html 2017-11-10T10:30:48.425Z https://www.astrazeneca.it/area-stampa/press-releases/2018.html 2018-01-15T16:52:51.657Z https://www.astrazeneca.it/area-stampa/press-releases/2018/osimertinib_tumorealpolmone_AURA3.html 2018-01-15T16:51:25.294Z https://www.astrazeneca.it/area-stampa/press-releases/2018/TopEmployers2017.html 2018-05-08T11:07:50.441Z https://www.astrazeneca.it/area-stampa/press-releases/2018/benralizumabEMA.html 2018-01-22T16:21:29.092Z https://www.astrazeneca.it/area-stampa/press-releases/2018/ticagrelor.html 2018-02-12T17:03:00.185Z https://www.astrazeneca.it/area-stampa/press-releases/2018/durvalumab.html 2018-02-21T14:20:57.038Z https://www.astrazeneca.it/area-stampa/press-releases/2018/topemployers2018.html 2018-02-21T14:40:50.097Z https://www.astrazeneca.it/area-stampa/press-releases/2018/studiocvdreal.html 2018-03-23T09:16:19.878Z https://www.astrazeneca.it/area-stampa/press-releases/2018/campagnaioscelgodisapere.html 2018-05-08T14:56:50.854Z https://www.astrazeneca.it/area-stampa/press-releases/2018/patientadvocacynetwork2018.html 2018-05-09T12:29:16.457Z https://www.astrazeneca.it/area-stampa/press-releases/2018/trialsygma.html 2018-05-23T12:02:21.704Z https://www.astrazeneca.it/area-stampa/press-releases/2018/durvalumabPACIFICOS.html 2018-05-31T08:16:28.531Z https://www.astrazeneca.it/area-stampa/press-releases/2018/Osimertinib_Eu.html 2018-07-18T15:27:27.483Z https://www.astrazeneca.it/area-stampa/press-releases/2018/Solo1_olaparib.html 2018-07-18T15:11:44.551Z https://www.astrazeneca.it/area-stampa/press-releases/2018/Durvalumab_parerepositivoCHMP.html 2018-08-19T06:57:52.148Z https://www.astrazeneca.it/area-stampa/press-releases/2018/Nomina_Scott_Pescatore_VP_OBU.html 2018-09-25T21:44:03.779Z https://www.astrazeneca.it/area-stampa/press-releases/2018/Nomina_Chiara_Gargiulo_VP_RIA.html 2018-09-25T21:44:55.905Z https://www.astrazeneca.it/area-stampa/press-releases/2018/Benralizumab_BORA_ERS.html 2018-09-25T21:48:48.616Z https://www.astrazeneca.it/area-stampa/press-releases/2018/Dapaglifozin__DECLARE_top_line.html 2019-01-29T13:57:18.591Z https://www.astrazeneca.it/area-stampa/press-releases/2018/PACIFIC_OS_WCLC.html 2018-09-30T19:06:41.366Z https://www.astrazeneca.it/area-stampa/press-releases/2018/SOLO1_ESMO2018.html 2018-10-23T13:03:23.119Z https://www.astrazeneca.it/area-stampa/press-releases/2018/AHA_2018.html 2018-11-13T06:46:35.671Z https://www.astrazeneca.it/area-stampa/press-releases/2018/AHA_20181.html 2019-02-05T15:39:12.128Z https://www.astrazeneca.it/area-stampa/press-releases/2018/AA.html 2019-03-19T16:45:51.010Z https://www.astrazeneca.it/area-stampa/press-releases/2018/DECLAREsottoanalisi.html 2019-07-08T09:41:45.714Z https://www.astrazeneca.it/area-stampa/press-releases/2018/SENOMETASTATICO.html 2019-05-29T15:25:12.392Z https://www.astrazeneca.it/area-stampa/press-releases/2018/NOVELSTART.html 2020-01-23T10:51:44.424Z https://www.astrazeneca.it/area-stampa/press-releases/2018/PATIENTADVOCACYNETWORK.html 2019-05-29T16:02:31.760Z https://www.astrazeneca.it/area-stampa/press-releases/2018/DURVALUMAB_TumorePolmone.html 2019-06-05T09:04:04.704Z https://www.astrazeneca.it/area-stampa/press-releases/2018/OLAPARIB_TumorePancreas.html 2019-06-06T08:45:47.848Z https://www.astrazeneca.it/area-stampa/press-releases/2018/DAPAGLIFLOZIN_DECLARE_renaldata.html 2019-06-14T12:49:59.380Z https://www.astrazeneca.it/area-stampa/press-releases/2018/OLAPARIB_OVAIO_SOLOI_APPROVAZIONEEU.html 2019-06-21T09:17:00.978Z https://www.astrazeneca.it/area-stampa/press-releases/2018/NOMINA_OLIVEROS_MEDICALHEAD.html 2019-06-21T09:47:42.688Z https://www.astrazeneca.it/area-stampa/press-releases/2018/ACALABRUTINIB_LLC_ASCEND.html 2019-06-21T11:16:52.662Z https://www.astrazeneca.it/area-stampa/press-releases/2018/BENRALIZUMAB_CHMP_AUTOSOMMINISTRAZIONE.html 2019-07-02T09:34:05.203Z https://www.astrazeneca.it/area-stampa/press-releases/2018/NOMINA_DRIOL_HR.html 2019-07-02T10:25:24.554Z https://www.astrazeneca.it/area-stampa/press-releases/2018/DAPAGLIFLOZIN_CHMP_DECLARE_CVDATA.html 2019-07-08T12:04:11.243Z https://www.astrazeneca.it/area-stampa/press-releases/2018/LUNG_AMBITION_ALLIANCE.html 2019-07-18T13:43:54.322Z https://www.astrazeneca.it/area-stampa/press-releases/2018/HLR_FLAURA_OS.html 2019-08-29T08:23:53.638Z https://www.astrazeneca.it/area-stampa/press-releases/2018/DAPAGLIFLOZIN_DAPA-HF_ESC2019.html 2019-09-03T09:39:15.767Z https://www.astrazeneca.it/area-stampa/press-releases/2018/TICAGRELOR_THEMIS_ESC2019.html 2019-09-03T10:01:50.348Z https://www.astrazeneca.it/area-stampa/press-releases/2018/DURVALUMAB_CASPIAN_IASLC.html 2019-09-10T15:23:19.523Z https://www.astrazeneca.it/area-stampa/press-releases/2018/OSIMERTINIB_FLAURA_ESMO2019.html 2019-10-01T08:47:13.202Z https://www.astrazeneca.it/area-stampa/press-releases/2018/OLAPARIB_PAOLA_ESMO2019.html 2019-10-01T09:37:04.999Z https://www.astrazeneca.it/area-stampa/press-releases/2018/OLAPARIB_PROFOUND_PROSTATA_ESMO2019.html 2019-10-01T13:35:39.883Z https://www.astrazeneca.it/area-stampa/press-releases/2018/ACALABRUTINIB_ELEVATETN_ASH.html 2019-12-13T15:06:05.321Z https://www.astrazeneca.it/area-stampa/press-releases/2018/OSIMERTINIB_RIMBORSABILITA_1LINEA.html 2020-01-08T15:49:13.742Z https://www.astrazeneca.it/area-stampa/press-releases/2018/ASTRAZENECA_TOP_EMPLOYERS_2020.html 2020-03-30T12:18:35.562Z https://www.astrazeneca.it/area-stampa/press-releases/2018/ASTRAZENECA_COVID-19.html 2020-03-31T16:33:25.421Z https://www.astrazeneca.it/area-stampa/press-releases/2018/DAPAGLIFLOZIN_DAPACKD_ACC.html 2020-04-06T14:03:26.123Z https://www.astrazeneca.it/area-stampa/press-releases/2018/NOMINA_MIRKOMERLETTI.html 2020-04-16T11:26:02.438Z https://www.astrazeneca.it/area-stampa/press-releases/2018/OSIMERTINIB_NSCLC_ADAURA_ASCO.html 2021-05-28T06:19:00.473Z https://www.astrazeneca.it/area-stampa/press-releases/2018/DURVALUMAB_CASPIAN_SCLC_ASCO.html 2020-06-11T16:45:31.968Z https://www.astrazeneca.it/area-stampa/press-releases/2018/ACALABRUTINIB_LLC_EHA.html 2020-06-12T12:41:02.969Z https://www.astrazeneca.it/area-stampa/press-releases/2018/ASTRAZENECA_VACCINO_COVID19.html 2021-02-01T15:24:37.786Z https://www.astrazeneca.it/area-stampa/press-releases/2018/BUDESONIDE-GLICOPIRRONIO-FORMOTEROLO_ETHOS_BPCO.html 2020-06-26T09:30:42.942Z https://www.astrazeneca.it/area-stampa/press-releases/2018/OLAPARIB_PSP_AZ-MSD.html 2020-06-30T11:22:23.502Z https://www.astrazeneca.it/area-stampa/press-releases/2018/ASTRAZENECA_VACCINO_COVID-19.html 2021-02-01T15:26:36.897Z https://www.astrazeneca.it/area-stampa/press-releases/2018/DAPAGLIFLOZIN_DAPA-CKD_ESC.html 2020-09-07T09:13:26.627Z https://www.astrazeneca.it/area-stampa/press-releases/2018/DURVALUMAB_OK_UE_SCLC.html 2020-09-08T14:58:20.196Z https://www.astrazeneca.it/area-stampa/press-releases/2018/PENNABENRALIZUMAB_DISPONIBILITAITALIA.html 2020-09-17T13:54:05.037Z https://www.astrazeneca.it/area-stampa/press-releases/2018/OLAPARIB_SOLO-1_ESMO.html 2020-09-18T15:11:14.851Z https://www.astrazeneca.it/area-stampa/press-releases/2018/DURVALUMAB_PACIFIC_ESMO.html 2020-09-21T09:14:27.641Z https://www.astrazeneca.it/area-stampa/press-releases/2018/OLAPARIB_PROFOUND_ESMO.html 2020-09-23T11:18:15.535Z https://www.astrazeneca.it/area-stampa/press-releases/2018/BENRALIZUMAB_PONENTE.html 2020-11-09T10:38:24.779Z https://www.astrazeneca.it/area-stampa/press-releases/2018/DAPAGLIFLOZIN_HF_APPROVAZIONEEU.html 2020-11-09T14:52:45.083Z https://www.astrazeneca.it/area-stampa/press-releases/2018/ACALABRUTINIB_LLC_APPROVAZIONEEU.html 2020-11-10T11:07:31.836Z https://www.astrazeneca.it/area-stampa/press-releases/2018/OLAPARIB_PAOLAI_APPROVAZIONEEU.html 2020-11-12T09:25:10.190Z https://www.astrazeneca.it/area-stampa/press-releases/2018/OLAPARIB_PROFUND_APPROVAZIONEEU.html 2020-11-16T16:35:16.859Z https://www.astrazeneca.it/area-stampa/press-releases/2018/OLAPARIB_SENO_OVAIO_RIMBORSABILITA.html 2020-12-17T15:53:59.492Z https://www.astrazeneca.it/area-stampa/press-releases/2018/ASTRAZENECA_TOPEMPLOYER2021.html 2021-02-05T17:41:04.111Z https://www.astrazeneca.it/area-stampa/press-releases/2018/NOTASTAMPAESTRANEITAVENDITAMERCATIPARALLELI.html 2021-02-22T18:58:17.985Z https://www.astrazeneca.it/area-stampa/press-releases/2018/NOTASTAMPACONSEGNEVACCINO.html 2021-02-23T09:10:00.618Z https://www.astrazeneca.it/area-stampa/press-releases/2018/NOTASTAMPA_DATI_INGLESI_RWE.html 2021-03-04T14:17:42.275Z https://www.astrazeneca.it/privacy-policy.html 2018-07-15T20:03:28.572Z https://www.astrazeneca.it/informativa-cookies.html 2019-08-27T13:08:30.415Z https://www.astrazeneca.it/informazioni-legali-e-condizioni-di-utilizzo.html 2016-07-21T15:31:19.159Z https://www.astrazeneca.it/contattaci.html 2026-07-15T12:59:37.419Z https://www.astrazeneca.it/EFPIA.html 2026-06-30T13:10:50.549Z https://www.astrazeneca.it/modello-231.html 2025-04-04T09:00:44.470Z https://www.astrazeneca.it/covid-19.html 2021-06-21T09:07:29.710Z https://www.astrazeneca.it/covid-19/la-ricerca-e-sviluppo-del-vaccino-azd1222.html 2021-02-02T14:39:30.210Z https://www.astrazeneca.it/covid-19/non-solo-vaccino--gli-anticorpi-monoclonali-per-contrastare-lepi.html 2021-02-02T09:18:53.363Z https://www.astrazeneca.it/covid-19/area-stampa.html 2021-06-17T11:58:35.818Z https://www.astrazeneca.it/covid-19/il-nostro-impegno-per-rendere-disponibile-il-vaccino-contro-il-c.html 2021-03-06T09:35:06.340Z https://www.astrazeneca.it/covid-19/made-for-the-world-italy.html 2021-06-18T15:25:11.349Z https://www.astrazeneca.it/covid-19/made-for-the-world-italy/ultime-notizie.html 2021-12-02T13:53:06.431Z https://www.astrazeneca.it/covid-19/made-for-the-world-italy/ricerca-e-sviluppo.html 2021-06-21T14:20:36.778Z https://www.astrazeneca.it/covid-19/made-for-the-world-italy/il-nostro-impegno.html 2021-06-21T14:18:44.690Z https://www.astrazeneca.it/covid-19/made-for-the-world-italy/le-persone.html 2021-12-02T15:53:11.021Z https://www.astrazeneca.it/covid-19/made-for-the-world-italy/latest-from-covax.html 2021-06-21T05:23:18.362Z https://www.astrazeneca.it/whistleblowing.html 2024-05-06T10:15:48.894Z https://www.astrazeneca.it/informazioni-studi.html 2026-06-11T08:38:56.094Z